Search results for "MESH: Prevalence"

showing 8 items of 8 documents

Sensitive measure of prevalence and parasitaemia of haemosporidia from European blackbird (Turdus merula) populations: value of PCR-RFLP and quantita…

2006

8 pages; International audience; Haemosporidian parasites are common in birds in which they act as an important selective pressure. While most studies so far have focused on the effect of their prevalence on host life-history traits, no study has measured the effect of parasitaemia. We developed molecular methods to detect, identify and quantify haemosporidia in 2 natural populations of the Blackbird Turdus merula. Three different parasite genotypes were found - 1 Haemoproteus and 2 Plasmodium. A PCR-RFLP screening revealed that only approximately 3% of blackbirds were free of parasites, compared to the 34% of uninfected birds estimated by blood smear screening. A quantitative PCR (q-PCR) a…

0106 biological sciencesPlasmodiumMESH: ParasitemiaMESH: Protozoan Infections AnimalMESH : Protozoan Infections AnimalMESH : PrevalenceMESH : Bird DiseasesMESH : ParasitemiaParasitemia01 natural sciencesPlasmodiumPolymerase Chain ReactionMESH: Bird Diseases030308 mycology & parasitologylaw.inventionPCR-RFLPlawGenotype[ SDV.EE.IEO ] Life Sciences [q-bio]/Ecology environment/SymbiosisParasite hostingMESH: AnimalsPasseriformesProtozoan Infections AnimalMESH : Polymerase Chain ReactionPolymerase chain reactionGenetics0303 health sciencesbiologyInfectious DiseasesMESH: HaemosporidaMESH : Sensitivity and SpecificityPolymorphism Restriction Fragment Length[ SDV.MP.PAR ] Life Sciences [q-bio]/Microbiology and Parasitology/Parasitologyfield populationsprevalenceZoology010603 evolutionary biologySensitivity and SpecificityparasitaemiaApicomplexa03 medical and health sciencesparasitic diseasesAnimalsTurdus merula[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/ParasitologyMESH: PrevalenceMESH : Polymorphism Restriction Fragment Length[SDV.GEN]Life Sciences [q-bio]/GeneticsHost (biology)Bird DiseasesMESH: PlasmodiumMESH: Polymorphism Restriction Fragment LengthMESH: PasseriformesMESH: Polymerase Chain Reactionbiology.organism_classificationHaemosporidaMESH : PasseriformesMESH: Sensitivity and SpecificityMESH : PlasmodiumHaemoproteusVector (epidemiology)Animal Science and ZoologyParasitologyHaemoproteusMESH : AnimalsMESH : Haemosporida[ SDV.GEN ] Life Sciences [q-bio]/Geneticsreal-time PCR[SDV.EE.IEO]Life Sciences [q-bio]/Ecology environment/Symbiosis
researchProduct

Consequences of organ choice in describing bacterial pathogen assemblages in a rodent population

2017

SUMMARYHigh-throughput sequencing technologies now allow for rapid cost-effective surveys of multiple pathogens in many host species including rodents, but it is currently unclear if the organ chosen for screening influences the number and identity of bacteria detected. We used 16S rRNA amplicon sequencing to identify bacterial pathogens in the heart, liver, lungs, kidneys and spleen of 13 water voles (Arvicola terrestris) collected in Franche-Comté, France. We asked if bacterial pathogen assemblages within organs are similar and if all five organs are necessary to detect all of the bacteria present in an individual animal. We identified 24 bacteria representing 17 genera; average bacterial…

0301 basic medicineOperational taxonomic unitMESH: Sequence Analysis DNAEpidemiologyMESH : PrevalenceMESH : Tissue DistributionRodent DiseasesRNA Ribosomal 16Sbacterial pathogensPrevalenceMESH : DNA BacterialTissue DistributionMESH: AnimalsPathogen[SDV.EE]Life Sciences [q-bio]/Ecology environmenteducation.field_of_studybiologyEcologyArvicolinaeMicrobiotaMESH : Rodent Diseases3. Good healthMESH: RNA Ribosomal 16SInfectious DiseasesArvicolinaeFrancerodent-borne pathogenDNA Bacterial030106 microbiologyPopulationShort ReportZoology[ SDV.EE ] Life Sciences [q-bio]/Ecology environment03 medical and health sciencesAnimalsMESH: MicrobiotaMESH : BacteriaMESH: Tissue DistributionArvicola terrestriseducationMESH : FranceMESH: Prevalence[ SDE.BE ] Environmental Sciences/Biodiversity and EcologyBacteriaHost (biology)tissue selectionBacteria PresentSequence Analysis DNAMESH: Arvicolinaebiology.organism_classificationMESH: DNA BacterialMESH: FranceMESH : ArvicolinaeMESH : RNA Ribosomal 16SMESH: BacteriaHigh-Throughput Sequencing030104 developmental biologyMESH : MicrobiotaSpecies richnessMESH: Rodent DiseasesMESH : Animals[SDE.BE]Environmental Sciences/Biodiversity and EcologyBacteriaMESH : Sequence Analysis DNA
researchProduct

Prevalence and genetic diversity of Aichi virus strains in stool samples from community and hospitalized patients.

2008

ABSTRACT Aichi virus has been proposed as a causative agent of gastroenteritis. A total of 457 stool specimens from children hospitalized with acute diarrhea and 566 stool specimens from adults and children involved in 110 gastroenteritis outbreaks were screened for the presence of Aichi virus by reverse transcription-PCR (RT-PCR) amplification of the genomic region of the 3C and 3D (3CD) nonstructural proteins. Our results show a low incidence of Aichi virus in pediatric samples and the existence of mixed infections with other microbiological agents in some cases. From the outbreak survey, it appears that the presence of Aichi virus is an indicator of mixed infections causing gastroenterit…

Aichi virusEpidemiologyMESH : PrevalenceMESH : DiarrheaMESH : KobuvirusDisease OutbreaksFecesMESH : ChildMESH: Picornaviridae InfectionsMESH: ChildMESH: AnimalsMESH: Genetic VariationMESH: PhylogenyChildPhylogeny0303 health sciencesCross InfectionMESH: KobuvirusMESH : Reverse Transcriptase Polymerase Chain ReactionMESH: Fecesvirus diseasesMESH : InfantMESH: Infant3. Good healthMESH : GastroenteritisMESH: DiarrheaMESH: Seafood[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyChild Preschool[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyAichi virusMESH : Cross InfectionMicrobiology (medical)DiarrheaMESH : Community-Acquired InfectionsKobuvirusMolecular Sequence Data[ SDV.MP.VIR ] Life Sciences [q-bio]/Microbiology and Parasitology/VirologyMESH: Ostreidae03 medical and health sciencesMESH : AdolescentHumansMESH : Disease OutbreaksMESH: PrevalenceMESH: AdolescentMESH : SeafoodMESH: HumansMESH: Molecular Sequence DataPicornaviridae Infections030306 microbiologyMESH: Child PreschoolMESH : HumansOutbreakGenetic VariationInfantDNAVirologyMESH: GastroenteritisSeafoodMESH : Sequence Analysis DNAMESH: Sequence Analysis DNAMESH : Molecular Sequence DataMESH : Child Preschool[ SDV.MP ] Life Sciences [q-bio]/Microbiology and ParasitologyMESH: Reverse Transcriptase Polymerase Chain ReactionGenotypePrevalenceMESH: Disease Outbreaks[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/VirologyMESH : Picornaviridae InfectionsbiologyReverse Transcriptase Polymerase Chain ReactionIncidence (epidemiology)MESH: Infant NewbornGastroenteritisCommunity-Acquired InfectionsDiarrheaMESH: Community-Acquired InfectionsKobuvirusFrancemedicine.symptomSequence AnalysisAdolescentMESH : Infant NewbornMESH : Genetic VariationGenetic variationmedicineAnimalsPreschoolMESH : FranceFeces030304 developmental biologyMESH : OstreidaeInfant NewbornMESH: Cross InfectionMESH : PhylogenySequence Analysis DNAMESH : Fecesbiology.organism_classificationNewbornOstreidaeMESH: FranceMESH : Animals
researchProduct

Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study

2011

Objectives: To provide a global, up-to-date picture of the prevalence, treatment, and outcomes of Candida bloodstream infections in intensive care unit patients and compare Candida with bacterial bloodstream infection. Design: A retrospective analysis of the Extended Prevalence of Infection in the ICU Study (EPIC II). Demographic, physiological, infection-related and therapeutic data were collected. Patients were grouped as having Candida, Gram-positive, Gram-negative, and combined Candida/bacterial bloodstream infection. Outcome data were assessed at intensive care unit and hospital discharge. Setting: EPIC II included 1265 intensive care units in 76 countries. Patients: Patients in partic…

Candida albicanMaleAntifungal AgentsIron metabolism Pathogenesis and modulation of inflammation [IGMD 7]Settore MED/41 - AnestesiologiaCritical Care and Intensive Care Medicinelaw.inventionEchinocandinschemistry.chemical_compound0302 clinical medicineRetrospective StudieCaspofunginlawCandida albicansPrevalenceAntifungal Agent030212 general & internal medicineCandida albicansFluconazoleMESH: SepsisFungemiaintensive careMedicine(all)MESH: AgedCross Infection0303 health scienceseducation.field_of_studyMESH: Middle AgedfungemiabiologyCandidiasisMiddle AgedIntensive care unitMESH: Candidiasisbacteremia; epidemiology; fungemia; intensive care; outcome assessment (health care); Aged; Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Echinocandins; Female; Fluconazole; Humans; Intensive Care Units; Lipopeptides; Male; Middle Aged; Prevalence; Retrospective Studies; Sepsis; Critical Care and Intensive Care Medicine3. Good healthIntensive Care Unitsbacteremia epidemiology fungemia intensive care outcome assessment (health care)CandidiasiMESH: FluconazoleepidemiologyFemaleHumanmedicine.drugmedicine.medical_specialtySepsiIntensive Care UnitPopulationLipopeptides03 medical and health sciencesSepsisIntensive caremedicineHumansEchinocandinbacteremiaIntensive care medicineeducationMESH: PrevalenceAgedRetrospective Studiesoutcome assessment (health care)MESH: Humans030306 microbiologybusiness.industryMESH: Candida albicansMESH: EchinocandinsMESH: Cross InfectionMESH: Retrospective Studies[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyMESH: Antifungal Agentsmedicine.diseasebiology.organism_classificationMESH: MalechemistryBacteremiaMESH: Intensive Care UnitsCaspofunginbusinessMESH: FemaleFluconazole
researchProduct

Emergence of Aspergillus fumigatus azole resistance in azole-naïve patients with chronic obstructive pulmonary disease and their homes.

2017

Azole-resistant Aspergillus fumigatus (ARAF) has been reported in patients with chronic obstructive pulmonary disease (COPD) but has not been specifically assessed so far. Here, we evaluated ARAF prevalence in azole-naïve COPD patients and their homes, and assessed whether CYP51A mutations were similar in clinical and environmental reservoirs. Sixty respiratory samples from 41 COPD patients with acute exacerbation and environmental samples from 36 of these patient's homes were prospectively collected. A. fumigatus was detected in respiratory samples from 11 of 41 patients (27%) and in 15 of 36 domiciles (42%). Cyp51A sequencing and selection on itraconazole medium of clinical (n = 68) and e…

Drug Resistance Fungal -- genetics0301 basic medicineAzolesMaleAntifungal AgentsExacerbationMESH: Fungal Proteins/isolation & purification[SDV]Life Sciences [q-bio]Colony Count MicrobialAspergillus fumigatusMESH: Aspergillus fumigatus/drug effectsMESH: Cytochrome P-450 Enzyme System/drug effectsMESH: GenotypePulmonary Disease Chronic ObstructivedwellingCytochrome P-450 Enzyme SystemGenotypePulmonary Disease Chronic Obstructive -- microbiologyPrevalenceProspective Studieschemistry.chemical_classificationMESH: AgedCOPDAzole-resistanceMESH: Middle AgedbiologyMESH: Drug Resistance Fungal/geneticsMold environmental exposureSciences bio-médicales et agricolesMiddle Aged3. Good healthMESH: Pulmonary Disease Chronic Obstructive/microbiology*MESH: Housing[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyAir Pollution IndoorAcute DiseaseDisease ProgressionMESH: Acute DiseaseMESH: Cytochrome P-450 Enzyme System/isolation & purificationMESH: Disease ProgressionFemalemedicine.drugmedicine.medical_specialtyEnvironmental EngineeringGenotypeItraconazoleMESH: Fungal Proteins/drug effects030106 microbiologyAspergillus fumigatus -- drug effects -- genetics -- isolation & purificationMESH: Azoles/pharmacology*Fungal Proteins -- drug effects -- isolation & purificationchronic obstructive pulmonary diseaseMicrobiologyFungal Proteins03 medical and health sciencesazole resistanceMESH: Air Pollution Indoor/analysis*Drug Resistance FungalInternal medicinemedicineCOPDHumansMESH: Aspergillus fumigatus/geneticsDwellingMESH: Colony Count MicrobialMESH: PrevalenceAgedAspergillusMESH: HumansAspergillus fumigatusAzoles -- pharmacologyelectrostatic dust collectorPublic Health Environmental and Occupational Healthmold environmental exposureElectrostatic dust collectorBuilding and Constructionmedicine.diseasebiology.organism_classificationMESH: MaleMESH: Prospective StudieschemistryCytochrome P-450 Enzyme System -- drug effects -- isolation & purificationHousingAzoleARAFMESH: Aspergillus fumigatus/isolation & purification*Antifungal Agents -- pharmacologyMESH: Antifungal Agents/pharmacology*MESH: FemaleAir Pollution Indoor -- analysisIndoor air
researchProduct

How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma a…

2009

International audience; BACKGROUND: Questionnaires are widely used in epidemiological studies to measure eczema symptom prevalence, but there are concerns regarding their accuracy if used as a diagnostic tool. OBJECTIVES: To compare the performance of a validated eczema symptom questionnaire and a standardized skin examination protocol employed in the second phase of the International Study of Asthma and Allergies in Childhood (ISAAC). METHODS: A total of 30,358 schoolchildren aged 8-12 years from 18 countries were examined for flexural eczema. Parents also completed an eczema symptom questionnaire. We compared prevalence estimates at the population level based on the questionnaire vs. phys…

MaleAllergymedicine.medical_specialtyEczemaPhysical examinationDermatologySeverity of Illness IndexAtopy030207 dermatology & venereal diseases03 medical and health sciencesMESH: Physical Examination0302 clinical medicineRisk Factorsimmune system diseasesMESH: Risk FactorsGermanySurveys and QuestionnairesMESH: ChildMESH: Severity of Illness IndexEpidemiologyPrevalenceotorhinolaryngologic diseasesmedicineHumans030212 general & internal medicineChildskin and connective tissue diseasesPhysical ExaminationMESH: GermanyMESH: PrevalenceAsthmaSymptom prevalenceMESH: Humansmedicine.diagnostic_testbusiness.industryMESH: QuestionnairesAtopic dermatitismedicine.diseaseMESH: Male3. Good healthSurgeryEl NiñoMESH: EczemaFamily medicineFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessMESH: Female
researchProduct

CTX-M β-Lactamase-Producing Escherichia coli in French Hospitals: Prevalence, Molecular Epidemiology, and Risk Factors▿

2007

ABSTRACT In 2004, 65 CTX-M-producing Escherichia coli isolates were collected from infected patients in four French hospitals. The bla CTX-M-15 genes were predominant. Pulsed-field gel electrophoresis highlighted a clonal propagation of CTX-M-15-producing strains belonging to phylogenetic group B2, notably in the community. The main risk factors for acquiring these isolates were urinary tract infections or the presence of a urinary catheter in diabetic or renal failure patients.

MaleMESH : Escherichia coliMESH : PrevalenceEpidemiologyMESH : AgedMESH: beta-LactamasesMESH: Urinary Tract Infectionsmedicine.disease_causeMESH: Risk Factors[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesRisk FactorsGenotypePrevalenceMESH : Urinary Tract InfectionsMESH : FemaleMESH: PhylogenyEscherichia coli InfectionsPhylogenyGel electrophoresisMESH: Aged0303 health sciencesMolecular EpidemiologybiologyMESH: Escherichia coliMESH : beta-LactamasesMESH: HospitalsEnterobacteriaceaeMESH : Risk FactorsHospitals3. Good healthElectrophoresis Gel Pulsed-FieldMESH : Hospitals[ SDV.MHEP.MI ] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesMESH: Electrophoresis Gel Pulsed-FieldMESH : Escherichia coli InfectionsUrinary Tract Infections[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesFemaleFranceMicrobiology (medical)Urinary systemMESH : Malebeta-LactamasesMicrobiologyMESH : Epidemiology Molecular03 medical and health sciencesMESH: Epidemiology MolecularmedicineEscherichia coliHumansRisk factorMESH : FranceEscherichia coliMESH: Prevalence030304 developmental biologyMESH : Electrophoresis Gel Pulsed-FieldMESH: Escherichia coli InfectionsAgedMESH: HumansMolecular epidemiology030306 microbiologyMESH : HumansMESH : Phylogenybiology.organism_classificationMESH: MaleMESH: FranceMESH: FemaleBacteria
researchProduct

Molecular Diagnosis of Toxoplasmosis in Immunocompromised Patients: a 3-Year Multicenter Retrospective Study

2015

ABSTRACT Toxoplasmosis is a life-threatening infection in immunocompromised patients (ICPs). The definitive diagnosis relies on parasite DNA detection, but little is known about the incidence and burden of disease in HIV-negative patients. A 3-year retrospective study was conducted in 15 reference laboratories from the network of the French National Reference Center for Toxoplasmosis, in order to record the frequency of Toxoplasma gondii DNA detection in ICPs and to review the molecular methods used for diagnosis and the prevention measures implemented in transplant patients. During the study period, of 31,640 PCRs performed on samples from ICPs, 610 were positive (323 patients). Blood ( n …

Microbiology (medical)Microbiological Techniquesmedicine.medical_specialtyMESH: Molecular Diagnostic TechniquesAsymptomaticPolymerase Chain Reactionlaw.inventionImmunocompromised Host[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseaseslawInternal medicinemedicineMESH: Immunocompromised HostPrevalenceHumansComputingMilieux_MISCELLANEOUSPolymerase chain reactionImmunodeficiencySurvival analysisMESH: PrevalenceRetrospective Studies[SDV.EE.SANT]Life Sciences [q-bio]/Ecology environment/HealthMESH: Humansbusiness.industryIncidence (epidemiology)MESH: ToxoplasmaMESH: Microbiological TechniquesRetrospective cohort studyMESH: Polymerase Chain ReactionMESH: Retrospective Studiesmedicine.diseaseSurvival AnalysisToxoplasmosis3. Good healthSurgeryMESH: France[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyMolecular Diagnostic TechniquesMESH: Survival AnalysisChemoprophylaxisMESH: ToxoplasmosisParasitologyFrancemedicine.symptombusinessToxoplasmaToxoplasmosis
researchProduct